v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE NON-CONTROLLING INTERESTS AND EQUITY - USD ($)
shares in Thousands, $ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Redeemable Non-Controlling Interests
Common Stock
Additional Paid-In Capital
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Non-Redeemable Non-Controlling Interests
Beginning Balance at Dec. 31, 2020     $ 787            
Redeemable Non-Controlling Interests                  
Recognition of non-controlling interest upon acquisition     56            
Derecognition of non-controlling interests upon divestiture $ (701)   (356)           $ (701)
Net income (loss)     (14)            
Ending Balance at Mar. 31, 2021     473            
Beginning balance (in shares) at Dec. 31, 2020       1,849,794          
Beginning balance at Dec. 31, 2020 12,967 $ (243)   $ 0 $ 35,931 $ (243) $ (535) $ (23,130) 701
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Exercise of stock options (in shares)       3,518          
Exercise of stock options 35       35        
Stock-based compensation 287       287        
Issuance of common stock for settlement of Careem Convertible Notes (in shares)       2,872          
Issuance of common stock for settlement of Careem Convertible Notes 158       158        
Issuance of common stock as consideration for acquisitions (in shares)       505          
Issuance of common stock as consideration for acquisition 28       28        
Issuance of common stock for settlement of RSUs (in shares)       10,924          
Shares withheld related to net share settlement (in shares)       (244)          
Shares withheld related to net share settlement (14)       (14)        
Derecognition of non-controlling interests upon divestiture (701)   (356)           (701)
Unrealized gain on investments in available-for-sale securities, net of tax 1,156           1,156    
Foreign currency translation adjustment 33           33    
Net income (loss) (108)             (108)  
Ending balance (in shares) at Mar. 31, 2021       1,867,369          
Ending balance at Mar. 31, 2021 $ 13,598     $ 0 36,182   654 (23,238) 0
Beginning Balance at Dec. 31, 2021     204            
Redeemable Non-Controlling Interests                  
Net income (loss)     1            
Ending Balance at Mar. 31, 2022     $ 205            
Beginning balance (in shares) at Dec. 31, 2021 1,949,316     1,949,316          
Beginning balance at Dec. 31, 2021 $ 15,145     $ 0 38,608   (524) (23,626) 687
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Exercise of stock options (in shares)       1,093          
Exercise of stock options 6       6        
Stock-based compensation 369       369        
Issuance of common stock for settlement of RSUs (in shares)       9,569          
Shares withheld related to net share settlement (in shares)       (316)          
Shares withheld related to net share settlement (11)       (11)        
Issuance of common stock for settlement of contingent consideration liability (in shares)       132          
Issuance of common stock for settlement of contingent consideration liability 5       5        
Unrealized gain on investments in available-for-sale securities, net of tax 0                
Foreign currency translation adjustment 19           19    
Net income (loss) $ (5,920)             (5,930) 10
Ending balance (in shares) at Mar. 31, 2022 1,959,794     1,959,794          
Ending balance at Mar. 31, 2022 $ 9,613     $ 0 $ 38,977   $ (505) $ (29,556) $ 697